But ADXS, for example is similar to IPIX to the extent it fell (well over 90%) from over $34 or so to less than $1 or so. But ADXS paid top staff at the millions level. Wasted money hugely and featured forced retirements where the greedy left with their money "unsued." And ADXS never finished a FDA 3, though if it did it appears that success was far from assured.